000 | 01924 a2200553 4500 | ||
---|---|---|---|
005 | 20250518020028.0 | ||
264 | 0 | _c20191104 | |
008 | 201911s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0209593 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPark, Jiesuck | |
245 | 0 | 0 |
_aTemporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study. _h[electronic resource] |
260 |
_bPloS one _c2019 |
||
300 |
_ae0209593 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
650 | 0 | 4 |
_aAtrial Fibrillation _xcomplications |
650 | 0 | 4 | _aBlood Coagulation |
650 | 0 | 4 |
_aCommunity Health Planning _xmethods |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolytic Agents _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xadverse effects |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 |
_aRepublic of Korea _xepidemiology |
650 | 0 | 4 |
_aStroke _xcomplications |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aChoi, Eue-Keun | |
700 | 1 | _aHan, Kyung-Do | |
700 | 1 | _aChoi, You-Jung | |
700 | 1 | _aLee, Euijae | |
700 | 1 | _aChoe, Wonseok | |
700 | 1 | _aLee, So-Ryoung | |
700 | 1 | _aCha, Myung-Jin | |
700 | 1 | _aLim, Woo-Hyun | |
700 | 1 | _aKang, Jeehoon | |
700 | 1 | _aPark, Kyung Woo | |
700 | 1 | _aOh, Seil | |
700 | 1 | _aLip, Gregory Y H | |
773 | 0 |
_tPloS one _gvol. 14 _gno. 1 _gp. e0209593 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0209593 _zAvailable from publisher's website |
999 |
_c29256577 _d29256577 |